53 related articles for article (PubMed ID: 18502461)
1. Influence of CYP3A5, ABCB1 and NR1I2 polymorphisms on prednisolone pharmacokinetics in renal transplant recipients.
Miura M; Satoh S; Inoue K; Kagaya H; Saito M; Inoue T; Habuchi T; Suzuki T
Steroids; 2008 Oct; 73(11):1052-9. PubMed ID: 18502461
[TBL] [Abstract][Full Text] [Related]
2. The pharmacogenetics of tacrolimus in renal transplant patients: association with tremors, new-onset diabetes and other clinical events.
Abderahmene A; Khalij Y; Moussa A; Ammar M; Ellouz A; Amor D; Abbes H; Ganouni MR; Sahtout W; Chouchene S; Omezzine A; Zellama D; Bouslama A
Pharmacogenomics J; 2024 Jan; 24(1):3. PubMed ID: 38253626
[TBL] [Abstract][Full Text] [Related]
3.
Seligson ND; Zhang X; Zemanek MC; Johnson JA; VanGundy Z; Wang D; Phelps MA; Roddy J; Hofmeister CC; Li J; Poi MJ
Front Pharmacol; 2023; 14():1334440. PubMed ID: 38259277
[No Abstract] [Full Text] [Related]
4. The hidden dangers of short-term glucocorticoid use in children: A genomic analysis.
Xu X; Li Y; Han T; Zhao Y; Wang X; Fu X; Mao H
Int Immunopharmacol; 2024 May; 135():112323. PubMed ID: 38788448
[TBL] [Abstract][Full Text] [Related]
5. The impact of CYP3A5*3 on oral quetiapine: A population pharmacokinetic model in Chinese bipolar disorder patients.
Lin M; Zhang Y; Lv D; Xu N; Yang X; Liu X; Yan C; Wu M; Kai J; Hu S; Zhao Q
J Affect Disord; 2024 Apr; 351():309-313. PubMed ID: 38262522
[TBL] [Abstract][Full Text] [Related]
6. Effects of CYP3A5*3 genetic polymorphisms on the pharmacokinetics of perampanel in Chinese pediatric patients with epilepsy.
Zhao T; Feng JR; Zhang HL; Yu J; Feng J; Sun KF; Yu LH; Sun Y; Li HJ
Pharmacogenet Genomics; 2024 May; ():. PubMed ID: 38728170
[TBL] [Abstract][Full Text] [Related]
7. Effect of polymorphisms in drug metabolism and transportation on plasma concentration of atorvastatin and its metabolites in patients with chronic kidney disease.
Jiang Z; Wu Z; Liu R; Du Q; Fu X; Li M; Kuang Y; Lin S; Wu J; Xie W; Shi G; Peng Y; Zheng F
Front Pharmacol; 2023; 14():1102810. PubMed ID: 36923356
[TBL] [Abstract][Full Text] [Related]
8. A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease.
Tziastoudi M; Pissas G; Raptis G; Cholevas C; Eleftheriadis T; Dounousi E; Stefanidis I; Theoharides TC
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923087
[TBL] [Abstract][Full Text] [Related]
9. Equations to estimate prednisone dose using body weight.
Emma F; Montini G; Gargiulo A
Pediatr Nephrol; 2019 Apr; 34(4):685-688. PubMed ID: 30368613
[TBL] [Abstract][Full Text] [Related]
10. Effects of polymorphisms in NR1I2, CYP3A4, and ABC transporters on the steady-state plasma trough concentrations of bosutinib in Japanese patient with chronic myeloid leukemia.
Abumiya M; Mita A; Takahashi S; Yoshioka T; Kameoka Y; Takahashi N; Miura M
Med Oncol; 2018 May; 35(6):90. PubMed ID: 29736778
[TBL] [Abstract][Full Text] [Related]
11. Personalized Medicine: New Perspectives for the Diagnosis and the Treatment of Renal Diseases.
Gluba-Brzózka A; Franczyk B; Olszewski R; Banach M; Rysz J
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28604601
[TBL] [Abstract][Full Text] [Related]
12. The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.
Hesselink DA; Bouamar R; Elens L; van Schaik RH; van Gelder T
Clin Pharmacokinet; 2014 Feb; 53(2):123-39. PubMed ID: 24249597
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical and genetic determinants for interindividual differences of tacrolimus bioavailability in renal transplant recipients.
Niioka T; Kagaya H; Miura M; Numakura K; Saito M; Inoue T; Habuchi T; Satoh S
Eur J Clin Pharmacol; 2013 Sep; 69(9):1659-65. PubMed ID: 23733010
[TBL] [Abstract][Full Text] [Related]
14. Associations of ABCB1, NFKB1, CYP3A, and NR1I2 polymorphisms with cyclosporine trough concentrations in Chinese renal transplant recipients.
Zhang Y; Li JL; Fu Q; Wang XD; Liu LS; Wang CX; Xie W; Chen ZJ; Shu WY; Huang M
Acta Pharmacol Sin; 2013 Apr; 34(4):555-60. PubMed ID: 23503472
[TBL] [Abstract][Full Text] [Related]
15. Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.
Bergmann TK; Barraclough KA; Lee KJ; Staatz CE
Clin Pharmacokinet; 2012 Nov; 51(11):711-41. PubMed ID: 23018468
[TBL] [Abstract][Full Text] [Related]
16. Genetic polymorphisms influence the steroid treatment of children with idiopathic nephrotic syndrome.
Chiou YH; Wang LY; Wang TH; Huang SP
Pediatr Nephrol; 2012 Sep; 27(9):1511-7. PubMed ID: 22610055
[TBL] [Abstract][Full Text] [Related]
17. The role of genetics in drug dosing.
Ware N
Pediatr Nephrol; 2012 Sep; 27(9):1489-98. PubMed ID: 22358188
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanism of glucocorticoid resistance in inflammatory bowel disease.
De Iudicibus S; Franca R; Martelossi S; Ventura A; Decorti G
World J Gastroenterol; 2011 Mar; 17(9):1095-108. PubMed ID: 21448414
[TBL] [Abstract][Full Text] [Related]
19. Pharmacogenomics: a new paradigm to personalize treatments in nephrology patients.
Zaza G; Granata S; Sallustio F; Grandaliano G; Schena FP
Clin Exp Immunol; 2010 Mar; 159(3):268-80. PubMed ID: 19968662
[TBL] [Abstract][Full Text] [Related]
20. Tacrolimus population pharmacokinetic-pharmacogenetic analysis and Bayesian estimation in renal transplant recipients.
Benkali K; Prémaud A; Picard N; Rérolle JP; Toupance O; Hoizey G; Turcant A; Villemain F; Le Meur Y; Marquet P; Rousseau A
Clin Pharmacokinet; 2009; 48(12):805-16. PubMed ID: 19902988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
